We are live on ! Find out more
AERI

Aerie Pharmaceuticals
AERI

Delisted

AERI was delisted on the 18th of November, 2022.

Back to rankings

49 hedge funds and large institutions have $252M invested in Aerie Pharmaceuticals in 2013 Q4 according to their latest regulatory filings, with 49 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
49
Holders Change
+49
Holders Change %
–
% of All Funds
1.42%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.06%
New
49
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
TGHSA
TPG Group Holdings (SBS) Advisors
Texas
+$57.2M
2
Wellington Management Group
Wellington Management Group
Massachusetts
+$21.6M
3
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
+$5.44M
4
BC
Broadfin Capital
New York
+$5.1M
5
PI
Putnam Investments
Massachusetts
+$4.17M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
TGHSA
1
TPG Group Holdings (SBS) Advisors
Texas
$78.8M +$57.2M +4,387,466 New
CV
2
Clarus Ventures
Massachusetts
$62.3M +$45.2M +3,468,495 New
Wellington Management Group
3
Wellington Management Group
Massachusetts
$29.7M +$21.6M +1,654,803 New
Schroder Investment Management Group
4
Schroder Investment Management Group
United Kingdom
$7.5M +$5.44M +417,600 New
BC
5
Broadfin Capital
New York
$7.03M +$5.1M +391,232 New
PI
6
Putnam Investments
Massachusetts
$5.75M +$4.17M +320,100 New
WSA
7
Wall Street Associates
California
$5.58M +$4.04M +310,500 New
GPP
8
Great Point Partners
Connecticut
$5.54M +$4.02M +308,429 New
BBA
9
Baker Bros. Advisors
New York
$5.39M +$3.91M +300,000 New
DM
10
Deerfield Management
New York
$5.39M +$3.91M +300,000 New
PA
11
Perceptive Advisors
New York
$5.39M +$3.91M +300,000 New
Jennison Associates
12
Jennison Associates
New York
$4.61M +$3.35M +256,864 New
BFA
13
BlackRock Fund Advisors
California
$3.7M +$2.68M +206,093 New
WA
14
Wasatch Advisors
Utah
$3.14M +$2.28M +175,000 New
BIT
15
BlackRock Institutional Trust
California
$2.47M +$1.79M +137,328 New
IHM
16
Iguana Healthcare Management
New York
$2.02M +$1.47M +112,500 New
SFM
17
Sphera Funds Management
Israel
$1.98M +$1.43M +110,000 New
Millennium Management
18
Millennium Management
New York
$1.92M +$1.39M +106,940 New
Northern Trust
19
Northern Trust
Illinois
$1.86M +$1.35M +103,594 New
Fidelity Investments
20
Fidelity Investments
Massachusetts
$1.8M +$1.3M +100,000 New
Vanguard Group
21
Vanguard Group
Pennsylvania
$1.65M +$1.2M +92,100 New
State Street
22
State Street
Massachusetts
$1.19M +$860K +66,056 New
Alyeska Investment Group
23
Alyeska Investment Group
Illinois
$925K +$671K +51,508 New
USAA
24
United Services Automobile Association
Texas
$823K +$597K +45,800 New
Geode Capital Management
25
Geode Capital Management
Massachusetts
$672K +$488K +37,463 New
1
2

AERI Hedge Fund Activity: Q4 2013 in Review

49 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Aerie Pharmaceuticals (AERI) for Q4 2013, worth a combined $252M.

Buyers outnumbered sellers: 49 funds opened new AERI positions and 0 closed out — a net gain of 49 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was TPG Group Holdings (SBS) Advisors, opening a new position worth an estimated $57.2M.

  • 49 institutional investors held Aerie Pharmaceuticals (AERI) as of Q4 2013, up from 0 in Q3 2013.
  • Funds reported $252M of Aerie Pharmaceuticals stock for Q4 2013.
  • 49 funds opened new Aerie Pharmaceuticals positions in Q4 2013 and 0 closed out, a net change of +49 holders.
  • The largest Aerie Pharmaceuticals buyer in Q4 2013 was TPG Group Holdings (SBS) Advisors, an estimated $57.2M added.

Based on aggregated 13F filings for Q4 2013.